---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-23-000122"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2023-10-16T23:59:59+00:00"
generated_at: "2026-06-09T23:07:42.712354+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# PacBio appoints former Moderna CFO David Meline to board of directors

## Summary
- David Meline appointed as Class II director effective October 13, 2023, term expiring at 2024 annual meeting.
- Meline most recently served as CFO of Moderna; previously CFO of Amgen and 3M, with 20+ years at GM.
- He also serves on boards of ABB Ltd. and will join HP Inc. board on November 1, 2023.
- Meline will participate in standard non-employee director compensation policy and indemnification agreement.

## SEC filing metadata
- accession: 0001299130-23-000122
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2023-10-16T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913023000122/0001299130-23-000122-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913023000122/pacb-20231016.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-23-000122
- JSON: https://secwatch.observer/filing/0001299130-23-000122.json
- Plain text: https://secwatch.observer/filing/0001299130-23-000122.txt

## Key facts
- Executive change
  David Meline was appointed as Class II Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..
  - Action: appointed
  - Role: Class II Director
  source text: On October 13, 2023, the Board (the “Board”) of Pacific Biosciences of California, Inc. (the “Company”) increased the size of the Board to ten directors and, upon the recommendation of its Corporate Governance and Nominating Committee, appointed David Meline to serve as a Class II director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913023000122/0001299130-23-000122-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.